Alessandra Bisi

3.9k total citations
120 papers, 3.3k citations indexed

About

Alessandra Bisi is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Alessandra Bisi has authored 120 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pharmacology, 49 papers in Organic Chemistry and 48 papers in Molecular Biology. Recurrent topics in Alessandra Bisi's work include Cholinesterase and Neurodegenerative Diseases (37 papers), Computational Drug Discovery Methods (29 papers) and Estrogen and related hormone effects (18 papers). Alessandra Bisi is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (37 papers), Computational Drug Discovery Methods (29 papers) and Estrogen and related hormone effects (18 papers). Alessandra Bisi collaborates with scholars based in Italy, Germany and Spain. Alessandra Bisi's co-authors include Angela Rampa, Silvia Gobbi, Federica Belluti, Vincenza Andrisano, Andrea Cavalli, Maurizio Recanatini, Manuela Bartolini, Piero Valenti, Lorna Piazzi and Rolf W. Hartmann and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Alessandra Bisi

117 papers receiving 3.3k citations

Peers

Countries citing papers authored by Alessandra Bisi

Since Specialization

Citations

This map shows the geographic impact of Alessandra Bisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bisi more than expected).

Fields of papers citing papers by Alessandra Bisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Bisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bisi. The network helps show where Alessandra Bisi may publish in the future.

Co-authorship network of co-authors of Alessandra Bisi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Bisi. A scholar is included among the top collaborators of Alessandra Bisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Bisi. Alessandra Bisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models 2024 ·Biomedicine & Pharmacotherapy ·Michela Rossi, C. Pellegrino, (unknown), Giovanna Farruggia, Dario de Biase, Silvia Cetrullo, Sarah D’Adamo, Alessandra Bisi, Paolo Blasi, Emil Malucelli, Concettina Cappadone, Silvia Gobbi	3
2	Targeting neuronal calcium channels and GSK3β for Alzheimer’s disease with naturally-inspired Diels-Alder adducts 2022 ·Bioorganic Chemistry ·Alessandra Bisi, Alessandra Feoli, Alfonso Trezza, (unknown), (unknown), Manuela Bartolini, Federica Belluti, Silvia Gobbi, Ottavia Spiga, Marco Caprini, Cristóbal de los Rı́os, Sabrina Castellano, Angela Rampa	7
3	Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Angelo Spinello, Federica Belluti, Alessandra Bisi, Nadia Zaffaroni, Alessandra Magistrato, Silvia Gobbi	6
4	Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm 2021 ·Research in Microbiology ·Francesca Bonvicini, Federica Belluti, Alessandra Bisi, Silvia Gobbi, Ilse Manet, Giovanna Angela Gentilomi	13
5	Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Angelo Spinello, Matic Pavlin, Eleonora Turrini, Federica Simonelli, Federica Belluti, Angela Rampa, Alessandra Bisi, Carmela Fimognari, Nadia Zaffaroni, Silvia Gobbi, Alessandra Magistrato	19
6	New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators 2021 ·Molecules ·Serena Montanari, Marco Allarà, Laura Scalvini, (unknown), Federica Belluti, Silvia Gobbi, Marina Naldi, Silvia Rivara, Manuela Bartolini, Alessia Ligresti, Alessandra Bisi, Angela Rampa	12
7	Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery 2020 ·Molecules ·Francesca Seghetti, Rita Maria Concetta Di Martino, Elena Catanzaro, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Barbara Canonico, (unknown), Dmitri V. Krysko, Stefano Papa, Carmela Fimognari, Federica Belluti	20
8	Targeting the Bacterial Membrane with a New Polycyclic Privileged Structure: A Powerful Tool To Face Staphylococcus aureus Infections 2019 ·ACS Infectious Diseases ·Francesca Bonvicini, Ilse Manet, Federica Belluti, Silvia Gobbi, Angela Rampa, Giovanna Angela Gentilomi, Alessandra Bisi	13
9	Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent 2019 ·Bioorganic Chemistry ·Elena Catanzaro, Francesca Seghetti, Cinzia Calcabrini, Angela Rampa, Silvia Gobbi, Piero Sestili, Eleonora Turrini, Francesca Maffei, Patrizia Hrelia, Alessandra Bisi, Federica Belluti, Carmela Fimognari	19
10	Identification of chalcone-based antileishmanial agents targeting trypanothione reductase 2018 ·European Journal of Medicinal Chemistry ·(unknown), Andrea Ilari, Gianni Colotti, (unknown), Theo Battista, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Rita Maria Concetta Di Martino, Giovanna Angela Gentilomi, Stefania Varani, Federica Belluti	61
11	Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment 2018 ·European Journal of Medicinal Chemistry ·Alessandra Bisi, (unknown), Matteo Micucci, Roberta Budriesi, Alessandra Feoli, Sabrina Castellano, Federica Belluti, Silvia Gobbi, Cristóbal de los Rı́os, Angela Rampa	20
12	Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity 2017 ·European Journal of Medicinal Chemistry ·Alessandra Bisi, Concettina Cappadone, Angela Rampa, Giovanna Farruggia, Azzurra Sargenti, Federica Belluti, Rita Maria Concetta Di Martino, Emil Malucelli, (unknown), Stefano Iotti, Silvia Gobbi	70
13	Fluorinated benzophenone derivatives: Balanced multipotent agents for Alzheimer's disease 2014 ·European Journal of Medicinal Chemistry ·Federica Belluti, Angela De Simone, Andrea Tarozzi, Manuela Bartolini, (unknown), Alessandra Bisi, Silvia Gobbi, Serena Montanari, Andrea Cavalli, Vincenza Andrisano, Giovanni Bottegoni, Angela Rampa	20
14	Multi-target strategy to address Alzheimer’s disease: Design, synthesis and biological evaluation of new tacrine-based dimers 2011 ·European Journal of Medicinal Chemistry ·Stefano Rizzo, Alessandra Bisi, Manuela Bartolini, Francesca Mancini, Federica Belluti, Silvia Gobbi, Vincenza Andrisano, Angela Rampa	34
15	From Nonsteroidal Aromatase Inhibitors to Multifunctional Drug Candidates: Classic and Innovative Strategies for the Treatment of Breast Cancer 2008 ·Current Topics in Medicinal Chemistry ·Silvia Gobbi, Andrea Cavalli, Alessandra Bisi, Maurizio Recanatini	13
16	New derivatives of xanthenone-4-acetic acid: Synthesis, pharmacological profile and effect on TNF-α and NO production by human immune cells 2006 ·Bioorganic & Medicinal Chemistry ·Silvia Gobbi, Federica Belluti, Alessandra Bisi, Lorna Piazzi, Angela Rampa, (unknown), Mariagnese Barbera, Anna Caputo, Maria Carrara	10
17	1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety 2005 ·Bioorganic & Medicinal Chemistry ·Roberta Budriesi, Alessandra Bisi, Pierfranco Ioan, Angela Rampa, Silvia Gobbi, Federica Belluti, Lorna Piazzi, Piero Valenti, Alberto Chiarini	35
18	Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism 2003 ·Bioorganic & Medicinal Chemistry ·Alessandra Bisi, Angela Rampa, Roberta Budriesi, Silvia Gobbi, Federica Belluti, Pierfranco Ioan, Ermanno Valoti, Alberto Chiarini, Piero Valenti	29
19	Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives 2000 ·Bioorganic & Medicinal Chemistry ·Angela Rampa, Alessandra Bisi, Federica Belluti, Silvia Gobbi, Piero Valenti, Vincenza Andrisano, Vanni Cavrini, Andrea Cavalli, Maurizio Recanatini	84
20	4-Heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect 1991 ·Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) ·Angela Rampa, Anna Chiarini, Alessandra Bisi, Roberta Budriesi, Piera Valenti	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact